Wednesday, UBS reiterated its Neutral rating on Nike (NYSE:NKE) shares with a set price target of $73.00. With Nike’s stock trading near its 52-week low at $71.34 and showing a -32.3% return over the past year, UBS’s analysis suggests that Nike may face challenges achieving strong growth and margin recovery in the near future, particularly in the Chinese market. InvestingPro data reveals that analysts broadly anticipate sales decline in the current year, with revenue already down -4.97% over the last twelve months. The firm hosted a discussion with an expert on Nike’s business in China, concluding that a significant rebound for Nike in China is unlikely soon. They predict negative revenue growth for Nike for the remainder of the current fiscal year, followed by flat to low single-digit percentage growth. This aligns with InvestingPro’s comprehensive analysis, which shows Nike’s total revenue at $48.98B and indicates challenging market conditions ahead. For deeper insights into Nike’s financial health and growth prospects, investors can access the detailed Pro Research Report, available exclusively to InvestingPro subscribers.
According to UBS, the EBIT margin for Nike’s Greater China region is expected to stay at its current low levels. This forecast contrasts with a slightly more optimistic market expectation, as inferred from conversations with investors. The firm’s stance remains unchanged, as they believe the market has already priced in a moderate level of optimism regarding Nike’s performance.
The expert’s insights, combined with UBS’s analysis, point to a cautious outlook for Nike, especially considering the importance of the Chinese market to the company’s overall performance. Nike’s new CEO, Elliott Hill, is faced with the challenge of steering the company back to sustainable growth and healthy EBIT margins, a task that UBS anticipates will not yield immediate significant results.
UBS’s price target of $73.00 remains in place, reflecting their neutral view on the stock’s potential for growth against the backdrop of current market conditions and internal challenges within Nike. While InvestingPro’s Fair Value analysis suggests Nike may be slightly undervalued at current levels, the firm’s assessment implies that investors should temper their expectations for Nike’s near-term financial recovery, particularly in the Greater China region.
In other recent news, Nike has been the subject of multiple analyst reports. Williams Trading maintained a Buy rating on the company with a $93 target, praising the new leadership’s direction and strategies. Bernstein analysts reiterated an Outperform rating with a $102 target, noting significant strides in clearing inventory and expressing optimism for the performance footwear segment. Piper Sandler kept an Overweight rating and a $90 target, highlighting Nike’s proactive measures and potential for reducing corporate overhead. BMO Capital Markets lifted its price target from $92 to $95, maintaining an Outperform rating and expressing confidence in Nike’s ability to navigate industry challenges. These developments underscore the analysts’ faith in Nike’s new leadership and strategic direction.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.